Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2010
05/12/2010CN101461925B Medicament composition for treating hepatopathy and preparation method thereof
05/12/2010CN101317964B Chinese medicinal composition with spleen-enlivening and kidney-tonifying function, preparation and uses thereof
05/12/2010CN101288722B Camellia oil liposome for treating snore and xerostomia
05/12/2010CN101215308B Method for producing ursodeoxycholic acid by using swine bladder as raw material
05/12/2010CN101190210B Application of triacontanol in preparing anti-cancer medicine
05/12/2010CN101176777B Chinese medicine composition and extract for preventing and treating stomach and intestine dysfunction as well as application thereof
05/12/2010CN101172116B Composition, preparing method and application of the same
05/12/2010CN101143155B Double ginseng composition and its application
05/12/2010CN101108229B Medicament for treating tummy bug
05/12/2010CN101092405B Derivative of new benzothiadiazines, preparation method and usage
05/12/2010CN101091763B Method for detection of tonic tablet for essence and blood
05/12/2010CN101069701B Ant-ganoderma particles and preparating method
05/12/2010CN101068798B Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
05/12/2010CN101057906B Traditional Chinese medicinal composition for treating hepatitis and its pharmaceutical preparation and application
05/12/2010CN101049463B Preparation of Chinese traditional medicine in use for hepatic disease and preparation method
05/12/2010CN101016299B Process for preparing purine derivatives
05/12/2010CN101011530B Method for preparation of health care wine for physical power recovery and Yang establishment
05/12/2010CN100998638B Traditional Chinese medicine for nourishing liver and kidney, nourishing blood and invigorating the circulation of blood
05/11/2010US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713949 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers
05/11/2010US7713532 isolated hepatitis B virus (HBV) core-like particle comprising an HBV precore protein, and further not comprising HBV DNA ; vaccines; assay kit comprising an anionic surfactant and an antibody that recognizes amino acids at positions -28 to 150 of the HBV precore protein
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713514 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
05/11/2010CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines
05/11/2010CA2274033C Biomaterial derived from vertebrate liver tissue
05/06/2010WO2010050583A1 Agent having anti-helicobacter pylori activity
05/06/2010WO2010050456A1 Piperidine compound having di- or tri-arylmethyl structure
05/06/2010WO2010050423A1 Ondansetron-containing external drug composition
05/06/2010WO2010050422A1 Agent for treatment of diabetes
05/06/2010WO2010050369A1 Prophylactic agent for dental caries
05/06/2010WO2010050181A1 Vaccine for preventing onset and recurrence of liver cancer induced by hepatitis c virus
05/06/2010WO2010050179A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
05/06/2010WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
05/06/2010WO2010050109A1 Kit for producing double-stranded rna with lactic acid bacterium, and use thereof
05/06/2010WO2010049954A1 Fatty acids for use as a medicament
05/06/2010WO2010049433A2 Water insoluble polymer: starch-based film coatings for colon targeting
05/06/2010WO2010049432A1 Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting
05/06/2010WO2010049144A2 Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (nr1f3) activity
05/06/2010WO2010029497A8 Treatment of endometriosis
05/06/2010WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
05/06/2010WO2009158625A3 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
05/06/2010WO2009057165A8 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
05/06/2010US20100113820 asthma, allergic conditions such as rhinitis, inflammatory bowel disease such as ulcerative colitis and Crohn's disease, rheumatoid arthritis, atopic dermatitis, multiple sclerosis; condensing N-(2,6-Difluorobenzoyl)-4-(2,6-dimethoxy-4-formal methylphenyl)-L-phenylalanine ethyl ester with ethanol
05/06/2010US20100113796 Indole derivatives as s1p1 receptor
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113597 Pharmaceutical composition for prevention of progress of intestinal constriction associated with crohn's disease
05/06/2010US20100113596 Method for inhibiting liver fibrosis via retinoic acid derivative
05/06/2010US20100113567 Recombinant VSV For The Treatment of Tumor Cells
05/06/2010US20100113546 Imidazol-4-one and Imidazole-4-thione Compounds
05/06/2010US20100113541 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
05/06/2010US20100113528 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
05/06/2010US20100113527 Crystalline forms of dexlansoprazole
05/06/2010US20100113526 Process for the Preparation of Esomeprazole Magnesium Dihydrate
05/06/2010US20100113524 Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
05/06/2010US20100113511 Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
05/06/2010US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds
05/06/2010US20100113471 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors
05/06/2010US20100113431 N-methyl piperazine modulators of h1 receptor
05/06/2010US20100113405 Methylindazole modulators of 5-ht3 receptors
05/06/2010US20100113402 Compositions for treatment of inflammatory diseases
05/06/2010US20100113398 Treatment and/or Prevention of Non-Viral Epithelial Damage
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113387 Fatty acids for use as a medicament
05/06/2010US20100113383 Bifidobacterial gene sequences and their use
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113356 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
05/06/2010US20100113354 Therapeutic agent comprising vasohibin
05/06/2010US20100112689 Method of obtaining viable human cells, including hepatic stem/progenitor cells
05/06/2010US20100112096 Dry extracts of pelargonium sidoides and pelargonium reniforme
05/06/2010US20100112088 Materials and methods for treatment of disorders associated with oxidative stress
05/06/2010US20100112066 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
05/06/2010US20100112003 Bifidobacterium in the treatment of inflammatory disease
05/06/2010US20100111915 Probiotics for reduction of risk of obesity
05/06/2010US20100111898 Conjoint therapy for treating fibrotic diseases
05/06/2010US20100111892 Crosslinked polyfluoroacrylic acid and processes for the preparation thereof
05/06/2010US20100111891 Linear polyol stabilized polyfluoroacrylate compositions
05/06/2010US20100111853 Antibodies that bind to il-12 and methods of purifying the same
05/06/2010DE102004059674B4 Transdermales System zur Abgabe von Scopolamin The transdermal delivery system of scopolamine
05/06/2010CA2742227A1 Fatty acids for use as a medicament
05/06/2010CA2740058A1 An antidiabetic agent
05/05/2010EP2181710A1 Ligands for modulation of orphan receptor-gamma (NR1F3) activity
05/05/2010EP2181122A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
05/05/2010EP2181114A1 New drugs with anticholestatic activity
05/05/2010EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/05/2010EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
05/05/2010EP1274414B1 Nasal administration of metoclopramide for the treatment of gastroparesis
05/05/2010EP1227803B1 compounds for inhibiting iapp-associated amyloid deposits
05/05/2010CN1985982B Medicine for treating colitis and its preparing method
05/05/2010CN1985947B Fire-clearing zhimai dripping pill and its preparing method
05/05/2010CN1953757B Composition for cleaning intestinal canal
05/05/2010CN1921875B Beverage and medicine having bamboo extractive as main component
05/05/2010CN1907987B Entecavir acid addition salt, preparation method and use thereof
05/05/2010CN1903208B Adefovir dipivoxil oral disintegration tablets preparation method
05/05/2010CN1883443B A health buccal spray and method for preparing same
05/05/2010CN1872133B Honey refined cream of Grosvenor momordica, and preparation method
05/05/2010CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease